期刊文献+

人工智能在生殖内分泌领域中的应用

The application of artificial intelligence in the reproductive endocrinology
下载PDF
导出
摘要 随着人工智能(artificial intelligence,AI)在医学领域的广泛应用与迅猛发展,生殖内分泌亚专科作为妇产科重要的一部分,也越来越多地应用AI技术解决生殖内分泌疾病的诊断、治疗、健康管理、监督及预防等问题。本文将从AI发展简史及AI在生殖内分泌领域中的应用进行阐述,总结AI在生殖内分泌领域应用中的现状、可行性及局限性,为AI在生殖内分泌领域的研究提供更广阔的思路。 As artificial intelligence(AI)is widely used and rapidly developed in the medical field,more and more AI technology are applied to solve the problems of diagnosis,treatment,health management,supervision and prevention of reproductive endocrinology diseases.This article review briefly the history of AI development and the application of AI in the field of reproductive endocrinology,and summarized the current situation,feasibility,and limitations of the application of AI in the field of reproductive endocrinology so as to provide broader ideas for the research of AI in reproductive endocrinology.
作者 裴友娟 阮祥燕 鞠蕊 王月姣 蒋玲玲 马郡 Pei Youjuan;Ruan Xiangyan;Ju Rui;Wang Yuejiao;Jiang Lingling;Ma Jun(Department of Gynecological Endocrinology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China;Department of Gynaecology and Obstetrics,Beijing Huairou Hospital,Capital Medical University,Beijing 100041,China)
出处 《首都医科大学学报》 CAS 北大核心 2024年第4期566-572,共7页 Journal of Capital Medical University
基金 北京市医院管理中心“登峰”人才培养计划专项(DFL20181401)。
关键词 人工智能 生殖内分泌 机器学习 深度学习 ChatGPT artificial intelligence reproductive endocrinology machine learning deep learning ChatGPT
  • 相关文献

参考文献7

二级参考文献57

  • 1国家教委社会科学研究与艺术教育司组.自然辩证法概论[M].北京:高等教育出版社,1999..
  • 2Chen ZJ, Zhao H, He L, et al. Genome-wide association study identified susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3[J]. Nat Genet, 2011, 43(1):55-59.
  • 3Dewailly D, Lujan ME, Carmina E, et al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society[J]. Hum Rprod Update, 2014, 20(3): 334-352.
  • 4National Institutes of Health, Evidence-based Methodology Workshop on polycystic ovary syndrome: final report, December 3- 5, 20l 2[EB/OL]. [2015-09-08]. https://prevention. nih.gov/does/programs/peos/FinalRepolt.pdf.
  • 5Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystie ovary syndrome: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2013, 98(12):4565-4592.
  • 6Conway G, Dewailly D, Diamanti-Kandarakis E, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology[J]. Eur J Endocrinol, 2014, 171(4):P1-29.
  • 7Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81(1):19-25.
  • 8Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J]. Fertil Steril, 2009, 91(2): 456-488.
  • 9Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J]. Fertil Steril, 2012, 97(1 ):28-38.
  • 10Baldani DP, Skrgatic L, Ougoaag R. Polycytstic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women[J]. Int J Endocrinol. 2015, 2015:786362.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部